Abstract:Background: Hypertensive disorders of pregnancy are widespread and have long-standing implications for women's health. Historically, the management of "severe gestational hypertension," or the presence of severely elevated blood pressures without any other signs or symptoms of end-organ damage meeting the criteria for preeclampsia, has been unclear. The new American College of Obstetricians and Gynecologists guidelines based on expert opinion recommend that severe gestational hypertension be treated similarly to preeclampsia with severe features, but data regarding outcomes for women with this diagnosis have been limited. Objective: This study aimed to compare the maternal and perinatal sequelae of severe gestational hypertension with that of other types of hypertensive disorders of pregnancy. Study design: This is a retrospective cohort study of women with hypertensive disease of pregnancy who delivered at a single tertiary care center between February and December 2018. Women with chronic hypertension; hemolysis, elevated liver enzymes, and low platelet count syndrome; preexisting kidney, liver, rheumatologic, or hematologic disorders; or multifetal pregnancies were excluded. Women were categorized as having severe gestational hypertension if they had a sustained systolic blood pressure of >160 mm Hg or a diastolic blood pressure of >110 mm Hg without other criteria for preeclampsia. The primary comparison was between women with severe gestational hypertension and women with preeclampsia without severe features. Secondary comparisons included women with severe gestational hypertension vs women with other types of hypertensive disease of pregnancy. The primary outcome for this analysis was small-for-gestational-age birth. We also evaluated other maternal and neonatal morbidities including but not limited to pulmonary embolism, stroke, eclampsia, blood transfusion, mechanical ventilation, intensive care unit admission, death, 5-minute Apgar score of ≤4, umbilical cord pH, neonatal intensive care unit admission of >2 days, respiratory distress syndrome, and neonatal death. Bivariate analyses using chi-square tests and logistic regressions adjusting for race, ethnicity, age, body mass index, parity, and insurance status were performed to compare frequencies of outcomes for each type of hypertensive disease of pregnancy with those of severe gestational hypertension. Results: Of 2076 women eligible for inclusion, 12.2% (n=254) had severe gestational hypertension and 379 (18.2%) had preeclampsia without severe features. Although there was no difference in the odds of small-for-gestational-age birth between women with severe gestational hypertension and women with preeclampsia without severe features (14.7% vs 9.8%; adjusted odds ratio, 0.72; 95% confidence interval, 0.44-1.21), the latter were significantly less likely to receive a prescription for antihypertensive medication at discharge (OR 0.11, 95% CI 0.06-0.22) or to be readmitted postpartum (OR 0.14, 95% CI 0.04-0.50). Conclusion: There was no difference in the primary outcome, that is, rate of small-for-gestational-age birth, between women with severe gestational hypertension and women with preeclampsia without severe features. However, women with severe gestational hypertension had greater odds of other maternal and neonatal morbidities than women with preeclampsia without severe features or mild gestational hypertension. These findings support recent recommendations regarding the management of women with severe gestational hypertension.

Relationship of different kinds of gestational hypertensive diseases and pregnancy outcomes

Association of Hypertensive Disorders of Pregnancy with Infant Growth in the First 36 Months of Life

Comparing Maternal and Perinatal Outcomes in Pregnancies Complicated by Preeclampsia Superimposed Chronic Hypertension and Preeclampsia Alone

Population-based study on birth outcomes among women with hypertensive disorders of pregnancy and gestational diabetes mellitus

Hypertensive Disorders of Pregnancy and Risks of Adverse Pregnancy Outcomes: a Retrospective Cohort Study of 2368 Patients

Maternal and Perinatal Prognosis of Pregnancy with Chronic Hypertension and Analysis of Associated Factors

Evaluating the maternal and perinatal sequelae of severe gestational hypertension

Effect of Blood Pressure Control Level on Perinatal Outcomes in Women with Mild-Moderate Gestational Hypertension

Effects of Preeclampsia on Perinatal Outcomes in Women with Gestational Diabetes Mellitus: A Retrospective Cohort Study

Relationship Between Blood Lipid Levels of Pregnant Women with Glucose Metabolism Disorders and Perinatal Outcomes

Increased Adverse Pregnancy Outcomes Associated with Stage 1 Hypertension in a Low-Risk Cohort: Evidence from 47 874 Cases.

Increased Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a Low-Risk Cohort

Clinical significance of ultrasonic umbilical artery flow analysis in pregnancy with gestational diabetes mellitus

Impact of Hypertensive Disorder Complicating Pregnancy on Neonatal Mortality and Major Complications in Pre-Term Infants

The Maternal-Fetal Risk Factors of Hypertensive Disorders of Pregnancy and its Effects on Infant Complete Blood Count and Coagulation Factors

Retrospective analysis of perinatal outcomes of singleton pregnant women with early-onset severe preeclampsia superimposed on chronic hypertension

Analysis of Correlation Factors and Pregnancy Outcomes of Hypertensive Disorders of Pregnancy - A Secondary Analysis of A Random Sampling in Beijing, China

Impact of Hypertensive Disorders of Pregnancy on Neonatal Outcomes among Infants Born at 24+0–31+6 Weeks’ Gestation in China: A Multicenter Cohort Study

The Association of Hypertensive Disorders of Pregnancy with Infant Mortality, Preterm Delivery, and Small for Gestational Age

Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia

Impact of gestational hypertension and preeclampsia on low birthweight and small‐for‐gestational‐age infants in China: A large prospective cohort study